Between 2011 and 2013, germline BAP1 variants were also reported in association with cutaneous melanoma (CM) [4,5,6,7], malignant mesothelioma (MMe) [5,6,7,8], and renal cell carcinoma (RCC) [9,10]. This evidence concerns the gene BAP1 and renal cell carcinoma.